InflaRx (IFRX) Gross Margin (2023 - 2026)
InflaRx's (IFRX) quarterly Gross Margin came in at 5985.37% in Q2 2026, up 1197074.0% year-over-year from N/an in Q2 2025, and down 58.49% quarter-over-quarter from 14418.5% in Q4 2025.
Powered by 
Analysis
InflaRx (IFRX) Gross Margin (2023 - 2026) Analysis & Trends
InflaRx has disclosed Gross Margin across 4 years of filings, most recently posting 5985.37% for Q2 2026.
- In Q2 2026, Gross Margin rose 1197074.0% year-over-year to 5985.37%; the TTM figure through Jun 2026 stood at 3695.5% (down 102062.0% YoY), while the FY2025 annual figure was 24677.94%, down 2277718.0% from the prior year.
- Gross Margin came in at 5985.37% for Q2 2026 at InflaRx, down from 14418.5% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 744976.36% in Q4 2024 to a low of 20523.75% in Q4 2023.
- Average Gross Margin over 4 years is 66626.76%, with a median of 25.78% recorded in 2025.
- Year-over-year, Gross Margin jumped 76550011 bps in 2024 and slumped 73055786 bps in 2025.
- Over 4 years, Gross Margin stood at 20523.75% in 2023, then surged by 3730 bps to 744976.36% in 2024, then tumbled by 98 bps to 14418.5% in 2025, then plunged by 58 bps to 5985.37% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 5985.37% in Q2 2026, 14418.5% in Q4 2025, and 98.6% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 72.04% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 79.76% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 85.33% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 91.59% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 90.43% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 35.86% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 76.90% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 71.60% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 80.31% |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | 5,985.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,985.37% |
| Dec 31, 2025 | 14,418.50% |
| Sep 30, 2025 | 98.60% |
| Jun 30, 2025 | -5,985.37% |
| Mar 31, 2025 | -25.78% |
| Dec 31, 2024 | 744,976.36% |
| Sep 30, 2024 | 158.60% |
| Jun 30, 2024 | -5,376.69% |
| Mar 31, 2024 | -511.93% |
| Dec 31, 2023 | -20,523.75% |
| Sep 30, 2023 | -319.58% |